• Rare Disease News
  • contribute@patientworthy.com
Facebook-f Instagram Linkedin-in Pinterest Twitter
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet Our Team
    • Collaborative Content On Patient Worthy
    • Contact Us
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Memes
    • Events
    • Patient Worthy FAQs
  • Listen
  • Languages
    • Spanish / Español
    • Russian / русский
    • French / Français
  • Log In
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet Our Team
    • Collaborative Content On Patient Worthy
    • Contact Us
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Memes
    • Events
    • Patient Worthy FAQs
  • Listen
  • Languages
    • Spanish / Español
    • Russian / русский
    • French / Français
  • Log In
  • Join PW

Daily Archives: March 24, 2021

Home » Archives for March 24, 2021
Next Generation Sequencing Leads to New Options When Standard Treatments Fail

Next Generation Sequencing Leads to New Options When Standard Treatments Fail

  • Post author:Rose Duesterwald
  • Post published:March 24, 2021
  • Post category:Cancer/Rare Disease

No longer the new player on the team, next-generation sequencing (NGS) is well established as having an influence in clinical care. In recent years, NGS has been responsible for many…

Continue Reading Next Generation Sequencing Leads to New Options When Standard Treatments Fail
Raising Awareness to Address The Needs of Pemphigus Patients
source: pixabay.com

Raising Awareness to Address The Needs of Pemphigus Patients

  • Post author:Kendall Mason
  • Post published:March 24, 2021
  • Post category:Pemphigus and pemphigoid

Back in October, the International Pemphigus & Pemphigoid Foundation (IPPF) took another step in their plan to learn from and work with patients to increase awareness for pemphigus. They held…

Continue Reading Raising Awareness to Address The Needs of Pemphigus Patients
A Second Phase 3 Trial for Charcot-Marie-Tooth Disease Type 1A Begins this Month

A Second Phase 3 Trial for Charcot-Marie-Tooth Disease Type 1A Begins this Month

  • Post author:Trudy Horsting
  • Post published:March 24, 2021
  • Post category:Charcot-Marie-Tooth disease

A Phase 3 clinical trial run by Pharnext for Charcot-Marie-Tooth disease Type 1A (CMT1A) has just been awarded 13.3 million dollars. $7.2 million comes from existing shareholders and $6 million comes…

Continue Reading A Second Phase 3 Trial for Charcot-Marie-Tooth Disease Type 1A Begins this Month
Rare Diseases Often Cost Patients More in Indirect Expenses Than Therapies Themselves
source: pixabay.com

Rare Diseases Often Cost Patients More in Indirect Expenses Than Therapies Themselves

  • Post author:Trudy Horsting
  • Post published:March 24, 2021
  • Post category:Rare Disease

Rare disease therapies have an exorbitant cost. Fewer patients means higher costs in order to support the development of treatments. In the United States, 966 billion was spent in 2019…

Continue Reading Rare Diseases Often Cost Patients More in Indirect Expenses Than Therapies Themselves
Hypernatremia and Hyponatremia Worsen COVID-19 Outcomes
Source: www.pixabay.com

Hypernatremia and Hyponatremia Worsen COVID-19 Outcomes

  • Post author:Jessica Lynn
  • Post published:March 24, 2021
  • Post category:COVID-19/Hypernatremia/Hyponatremia

124 million cases worldwide, with 2.73 million associated deaths. These are the numbers for COVID-19, a novel coronavirus pandemic which, over the past 12-15 months, has swept the globe. In the…

Continue Reading Hypernatremia and Hyponatremia Worsen COVID-19 Outcomes
Rare Classroom: Multiple Myeloma
source: shutterstock

Rare Classroom: Multiple Myeloma

  • Post author:James Moore
  • Post published:March 24, 2021
  • Post category:Multiple Myeloma

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Multiple Myeloma
Niraparib + Bevacizumab Combo Prevents Ovarian Cancer Progression, Study Shows
Hans / Pixabay

Niraparib + Bevacizumab Combo Prevents Ovarian Cancer Progression, Study Shows

  • Post author:Jessica Lynn
  • Post published:March 24, 2021
  • Post category:Ovarian Cancer

During the Society of Gynecological Oncology 2021 Virtual Annual Meeting on Women’s Cancer, researchers presented data from the Phase 2 OVARIO clinical trial. According to Cancer Network, the trial evaluated…

Continue Reading Niraparib + Bevacizumab Combo Prevents Ovarian Cancer Progression, Study Shows
Understanding and Treating Chronic Kidney Disease (CKD)
Photo by Robina Weermeijer on Unsplash

Understanding and Treating Chronic Kidney Disease (CKD)

  • Post author:Kendall Mason
  • Post published:March 24, 2021
  • Post category:Chronic Kidney Disease

Chronic kidney disease (CKD) affects hundreds of millions of people throughout the world. As of 2017, 697.5 million people were estimated to have CKD by this study published in Nature Reviews…

Continue Reading Understanding and Treating Chronic Kidney Disease (CKD)

OF INTEREST



Rare Disease Clinical Trials Are Essential to Help Uncover Potential Patient Solutions: Spotlight on Classic Congenital Adrenal Hyperplasia (CAH)

GET INVOLVED

Make a difference, share your experiences and get paid. Opt-in & join Patient Worthy’s panel for paid opportunities such as Surveys, Market Research, Patient Advisory Panels & much more.

JOIN NOW

STUDY OF THE WEEK

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

READ MORE

RARE CLASSROOM

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most mysterious diseases and conditions. This series is an opportunity to learn the basics about some of the diseases that almost no one hears much about.

READ MORE
SIGN UP FOR OUR NEWSLETTER
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story
Become a Contributor

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Policy
Privacy Policy for CA Residents
EU Privacy Notice

© Copyright Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info